- Press Release Distribution

Researchers uncover genetic factors for severe Lassa fever

New findings from an international collaboration pave the way for studies of highly infectious diseases in Africa such as Ebola.

( While combing through the human genome in 2007, computational geneticist Pardis Sabeti made a discovery that would transform her research career. As a then postdoctoral fellow at the Broad Institute of MIT and Harvard, Sabeti discovered potential evidence that some unknown mutation in a gene called LARGE1 had a beneficial effect in the Nigerian population. Other scientists had discovered that this gene was critical for the Lassa virus to enter cells. Sabeti wondered whether a mutation in LARGE1 might prevent Lassa fever — an infection that is caused by the Lassa virus, is endemic in West Africa, and can be deadly in some people while only mild in others. 

To find out, Sabeti decided later in 2007, as a new faculty member at Harvard University, that one of the first projects her new lab at the Broad would take on would be a genome-wide association study (GWAS) of Lassa susceptibility. She reached out to her collaborator Christian Happi, now the Director of the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University in Nigeria, and together they launched the study. 

Now, their groups and collaborators report the results of that study in Nature Microbiology — the first ever GWAS of a biosafety level 4 (BSL-4) virus. The team found two key human genetic factors that could help explain why some people develop severe Lassa fever, and a set of LARGE1 variants linked to a reduced chance of getting Lassa fever. The work could lay the foundation for better treatments for Lassa fever and other similar diseases. The scientists are already working on a similar genetics study of Ebola susceptibility.

The paper also describes the many challenges the team had to overcome during their 16-year collaborative effort, such as studying a dangerous virus and recruiting patients with a disease that is not well documented in West Africa. Dozens of scientists contributed to the work and spent seven years recruiting patients in Nigeria and Sierra Leone and many additional years establishing the research program and analyzing the results. “It truly took a village to get this done,” said Happi, a co-senior author along with Sabeti. 

“Generations of people in our labs, across different institutions and countries, spent significant parts of their careers bringing this to fruition,” added Sabeti, an institute member at the Broad, a Howard Hughes Medical Institute investigator, a professor at the Center for Systems Biology and the Department of Organismic and Evolutionary Biology at Harvard University, and a professor in the Department of Immunology and Infectious Disease at the Harvard T. H. Chan School of Public Health.

The co-first authors of the study are Dylan Kotliar, an internal medicine resident at Brigham and Women’s Hospital and an MD/PhD student in Sabeti’s lab while the project was ongoing; Siddharth Raju, a graduate student in Sabeti’s lab; Shervin Tabrizi, a postdoctoral researcher at the Broad; and Ikponmwosa Odia, a researcher at Irrua Specialist Teaching Hospital in Nigeria. 

Lassa learnings

Sabeti recalls the team’s early discussions when launching the project. They knew they had to be cautious at every step: To work with a BSL-4 virus, scientists must wear pressurized suits connected to HEPA-filtered air in a special containment lab. The virus causes fever, sore throat, coughing, and vomiting, but can quickly progress to organ failure in some people.

“This was an extremely challenging study to get off the ground,” said Kotliar, who worked on the project throughout his entire PhD in the Sabeti lab. “I think the battle scars, the things we’ve learned along the way about how to get a project like this done, are going to be important for future research into viruses in developing countries.”

Finding participants for the study would be challenging too. There are currently no FDA-approved diagnostics for Lassa, and Lassa virus cases are typically not documented. There are fewer than 1,000 cases reported each year in Nigeria, the most populous country where the virus is endemic, and cases are often in rural areas far from diagnostic centers, many of which don’t have the technology to detect the virus. Infections with other viruses, and genomic complexity among different strains of the same Lassa virus can complicate analysis. Moreover, African populations have been historically underrepresented in past genetic studies, which reduces statistical power in data analyses and can make it difficult to identify key genetic variants. 

When Sabeti began thinking about how to start the project, she reached out to Happi, whom she knew through their mutual work on the malaria-causing pathogen, Plasmodium falciparum. With the help of collaborators including Peter Okokhere, a doctor treating Lassa patients at the Irrua Specialist Teaching Hospital, they began recruiting patients from both Nigeria and Sierra Leone. Then, they compared the genomes of about 500 people who’d had Lassa fever and nearly 2,000 who hadn’t.

In the Nigerian cohort, the team found that people with a set of variants in the LARGE1 gene — which modifies a cell receptor that binds to certain viruses — were less likely to get Lassa fever. Sabeti, Happi, and their colleagues also found genomic regions associated with Lassa fatality: in the LIF1 gene, which encodes an immune-signaling molecule, and, in the Nigerian cohort, the GRM7 gene, which is involved in the central nervous system. The team then used a large-scale screen called a massively parallel reporter assay to home in on which variants within these genomic regions might be functional and could be targets of new treatments.

Better detection

The researchers say that to improve detection and treatment of Lassa fever, more diagnostic centers and diagnostics that work in the field are needed, along with better health infrastructure to connect remote locations with major hospitals.

“This really highlights the need for continued investment in understanding African population genetics,” added Raju. “Even with a relatively limited sample set, we’ve increased our understanding of some African populations, specifically in immune-related genes — and that shows how much more there is to do going forward.”

Sixteen years after they first started thinking about the genetics of Lassa fever, Sabeti and Happi are excited about the study’s findings, which could explain the biological differences between mild and severe illness. They said the work also shows that, as thoughtful collaborations between countries, genome-wide association studies of BSL-4 viruses are possible. The researchers have already begun conducting a similar study of Ebola in Sierra Leone and Liberia, and other scientists are calling for increased pathogen surveillance and scientific training in Africa.

“We’re standing at a moment where we can actually start developing point-of-need diagnostics for Lassa virus and testing much more broadly,” Happi said. “We need better infrastructure, but I think we’ve shown that this kind of study is a worthwhile pursuit.”



This work was supported in part by the National Institute of Health, the German Research Foundation, and the Howard Hughes Medical Institute.


Paper cited:

Kotliar DK, Raju S, Tabrizi S, Odia I, et al. Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever. Nature Microbiology. Online February 7, 2024. DOI: 10.1038/s41564-023-01589-3.


About Broad Institute of MIT and Harvard

Broad Institute of MIT and Harvard was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.

Founded by MIT, Harvard, Harvard-affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide.



Leader in robotics at U-M and beyond elected to National Academy of Engineering

Feb. 8, 2024 Contact: Katherine McAlpine, 734-647-7087,    Image Leader in robotics at U-M and beyond elected to National Academy of Engineering Dawn Tilbury is recognized for advances in manufacturing network control and human-robot interaction, as well as engineering leadership ANN ARBOR—Dawn Tilbury, the Ronald D. and Regina C. McNeil Department Chair of Robotics at the University of Michigan, has been recognized with one of engineering's greatest honors—election to the National Academy of Engineering.  NAE members are outstanding researchers, ...

16 UTA scholars receive McNair federal research award

16 UTA scholars receive McNair federal research award
A competitive U.S. Department of Education program that prepares undergraduate students interested in careers in academic research has selected 16 undergraduate students from The University of Texas at Arlington to join. The McNair Scholars Program was named for physicist and astronaut Ronald E. McNair, the second Black astronaut in U.S. history and one of several crew members killed when the space shuttle Challenger exploded on Jan. 28, 1986. The program assists qualified first-generation ...

Nanofiber bandages fight infection, speed healing

ITHACA, N.Y. – Cornell University researchers have identified a new way to harness the antioxidant and antibacterial properties of a botanical compound to make nanofiber-coated cotton bandages that fight infection and help wounds heal more quickly. The findings are especially important given the increasing prevalence of multidrug-resistant bacteria. Cotton gauze is one of the most common wound dressings; it’s inexpensive, readily available, comfortable and biocompatible. However, it doesn’t promote healing or fight infection. “Cotton alone cannot provide an answer for these ...

Newly discovered genetic malfunction causes rare lung disease

Newly discovered genetic malfunction causes rare lung disease
The macrophage is one of the body’s most important inhabitants. Meaning “big eater” in Greek, this immune cell consumes and digests problematic elements from microbes and cancer cells to dust and debris. Macrophages are especially important in the lungs, where they both fight bacterial infection and clear the lungs of excess surfactant, a protein- and lipid-rich layer that’s essential to healthy function but can create a sticky buildup if not controlled. In a recent study, investigators from Rockefeller University ...

Even with resolution, acute kidney injury in newborns can be life-threatening from very first episode

Even with resolution, acute kidney injury in newborns can be life-threatening from very first episode
Our resilient kidneys are invaluable members of the body’s purification system, and they excel at bouncing back after injury. This even holds true for most sick infants in the neonatal intensive care unit. Because of this remarkable ability, dips in kidney function in infants were often overlooked historically in favor of other pressing diseases or symptoms. But physicians and researchers have shown increased interest in understanding kidney health in newborns and young infants within the last decade, leading to the AWAKEN study (Assessment of Worldwide Acute Kidney Epidemiology in Neonates). With initial ...

High-profile incidents of police brutality sway public opinion more than performance of people’s local law enforcement, new study from NYU Tandon reveals

National media coverage of police brutality influences public perceptions of law enforcement more than the performance of people’s local police departments, according to data analysis from NYU Tandon School of Engineering, challenging the assumption that public confidence in police depends mostly on feeling safe from local crime. In a study published in Communications Psychology, a NYU Tandon research team tracked media coverage of police brutality in 18 metropolitan areas in the United States – along with coverage of local crimes  – and analyzed tweets from those cities to tease out positive attitudes from negative ...

Why politics bring out the worst in us

Tap into any social media platform, turn on the television or cue up a podcast, and it is easy to find examples of hypocrisy or bad behavior in political discourse, and new research from University of Nebraska–Lincoln political scientists may explain why. The findings from a large survey study, co-authored by Kyle Hull, Kevin Smith and Clarisse Warren, demonstrate the willingness of people to bend their morals — even behave unethically — when engaging in the political realm. Results also suggest that hostility toward outgroups (i.e., opposing party) is the driving factor for the moral ambiguity exercised ...

How fruit flies control the brain's "steering wheel"

How fruit flies control the brains steering wheel
When we walk down the street, we have an internal sense of which way we are heading, from looking at street signals and physical landmarks, and also a sense of where we’d like to go. But how does the brain coordinate between these directions, doing the mental math that tells us which way to turn? Now, new research describes such a neural process in fruit flies, providing insight into how an animal’s brain steers it in the right direction. The study, published in Nature , shows how neurons that signal the direction in which a fly is currently oriented work together with neurons that signal the direction in which way the ...

SwRI’s Dr. Alan Stern named AIAA Fellow

SwRI’s Dr. Alan Stern named AIAA Fellow
SAN ANTONIO — February 8, 2024 —Dr. Alan Stern, a planetary scientist and associate vice president of Southwest Research Institute’s Space Sector, has been named a Fellow of the American Institute of Aeronautics and Astronautics (AIAA). Fellows are recognized for their notable and valuable contributions to the arts, sciences or technology of aeronautics and astronautics. AIAA cited Stern “for outstanding contributions to the exploration of the solar system and the development of commercial spaceflight.” “I am honored beyond words to be named an AIAA Fellow and thank my nominators very much, including SwRI Vice President Dr. Ben Thacker, who led the nomination,” ...

Visualising multiple sclerosis with a new MRI procedure

Visualising multiple sclerosis with a new MRI procedure
Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone. One key feature of the disease is that it causes the patient’s own immune system to attack and destroy the myelin sheaths in the central nervous system. These protective sheaths insulate the nerve fibres, much like the plastic coating around a copper wire. Myelin sheaths ensure that electrical impulses travel quickly and efficiently from nerve cell to nerve cell. If they are damaged or become thinner, this can lead to irreversible visual, ...


Many older adults receiving home care do not receive palliative care before death

Reforestation schemes are not enough to recover the carbon created by harvesting wood, research suggests

Antidepressant dispensing to adolescents and young adults surges during pandemic

Healthcare leaders plea to reinstate the Canadian hypertension control program to prevent death and disability

Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds

Measuring the properties of light: Scientists realise new method for determining quantum states

For faster access to gene and cell therapies in Europe

Scientists deliver portable total chemical analysis without pumps and tubes

A very long, winding road: Developing novel therapeutics for metastatic tumors

Unlocking health: How In Our DNA SC is pioneering genetic screening for South Carolinians

Down Under Demo: ONR touts additive manufacturing tech at Australian event

Study shows benralizumab is effective as a treatment for eosinophilic granulomatosis with polyangiitis, a rare form of vasculitis

Researchers identify new choice of therapy for rare autoimmune disease EGPA

Powering nitrogenases

NJIT marketing experts measure brain waves and skin current to predict emotions

Babies use immune system differently, but efficiently

Cloud clustering causes more extreme rain

Mindfulness at work protects against stress and burnout

Scientists closer to solving mysteries of universe after measuring gravity in quantum world

Revolutionary brain stimulation technique shows promise for treating brain disorders

Global warming increases the diversity of active soil bacteria

Patient mindset training helps care teams

Dual-energy harvesting device could power future wireless medical implants

Study: ‘Hexaplex’ vaccine aims to boost flu protection

New structural insights could lead to mechanical enhancement in alloys

New research challenges conventional picture of Parkinson's disease

Dairy cows fed botanicals-supplemented diets use energy more efficiently

Aston University receives nearly half a million pounds to create safer and greener batteries

New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

Sir Peter Rigby appointed as honorary chair of Aston University’s new Digital Futures Institute

[] Researchers uncover genetic factors for severe Lassa fever
New findings from an international collaboration pave the way for studies of highly infectious diseases in Africa such as Ebola.